# Hypoglycemia- and Weight-related Quality of Life in Patients With Diabetes Mellitus Type 2 on Sulfonylurea Derivatives.

> **NCT01244646** · — · TERMINATED · sponsor: **AstraZeneca** · enrollment: 48 (actual)

## Conditions studied

- Diabetes Mellitus Type 2

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01244646
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2010-12
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2012-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01244646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01244646, "Hypoglycemia- and Weight-related Quality of Life in Patients With Diabetes Mellitus Type 2 on Sulfonylurea Derivatives.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01244646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*